The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site

NIH Pandemic-Era Grants

Pandemic Era Grants

2024

Document text

Principal Investigator: Alison Katherine Conlin
Organization: SWEDISH MEDICAL CENTER, FIRST HILL
Fiscal Year: 2024
Award: $2,632,282
Funding agency: National Cancer Institute

In 2013, the Pacific Cancer Research Consortium (PCRC) was created to bring clinical trials and cancer care delivery research to community cancer treatment centers in the Western United States as an NCI Community Oncology Research Program (NCORP) Community Site. Under a multiple PI/PD structure, the 3 primary component sites—Swedish Cancer Institute in Seattle, Providence Portland Medical Center in Portland, and St. Luke’s Cancer Institute in Boise—have facilitated the conduct of NCORP-sponsored trials at more than 40 affiliate sites in Alaska, Washington, Oregon, Idaho, Montana, and California. Over the past 12 years, the PCRC built on its collective experience in clinical research, its shared organizational structure, and its community demographics to deliver accessible research trials, enhance community engagement in research, and provide quality cancer care. As an established NCORP Community Site, the PCRC will continue to “bring cancer clinical research studies to individuals in their own communities” by (1) conducting clinically important treatment trials that include robust accrual strategies and fair access for everyone, (2) participating in cancer control and prevention studies, cancer care delivery research, and screening, and imaging trials proposed by the NCORP Research Bases, (3) optimizing and streamlining procedures to ensure timely and accurate data submission and specimen collection, (4) enhancing visibility, recruitment, participation, education, and broad population engagement including patient advocates in NCORP activities, and (5) mentoring the next generation of community-based cancer clinical trialists.

Terms: <Acceleration><Address><Advocate><After Care><After-Treatment><Aftercare><Agreement><Alaska><CCOP><California><Cancer Center><Cancer Control><Cancer Control Science><Cancer Treatment><Cancers><Clinical><Clinical Research><Clinical Study><Clinical Trials><Clinical Trials Network><Collaborations><Collection><Communities><Community Clinical Oncology Program><Community Oncology><Credentialing><Disparities><Disparity><Ensure><Environment><Fostering><Funding><Generations><Goals><IRB><IRBs><Idaho><Image><Improve Access><Individual><Individuals from minority><Individuals of minority><Infrastructure><Institutional Review Boards><Investigators><Knowledge><Legal><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Medical center><Mentors><Minority Groups><Minority Participation><Minority People><Minority Population><Minority individual><Montana><NCI Organization><National Cancer Institute><Oregon><Organization Charts><Organizational Efficiency><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Population Heterogeneity><Prevention><Procedures><Process><Quality Control><Research><Research Personnel><Research Resources><Researchers><Resources><Science><Site><Structure><Underrepresented Groups><Underrepresented Populations><Underserved Population><United States><Washington><Work><anti-cancer research><anti-cancer therapy><base><bases><cancer care><cancer disparity><cancer health disparity><cancer prevention><cancer research><cancer therapy><cancer-directed therapy><cancer-related health disparity><care delivery><clinical practice><clinical significance><clinically significant><community setting><data deposition><data submission><demographics><disparity in cancer><disparity in health><diverse populations><evidence base><experience><feasibility trial><health disparity><heterogeneous population><imaging><improved><knowledge translation><malignancy><neoplasm/cancer><next generation><organizational structure><patient oriented outcomes><population diversity><post treatment><programs><quality assurance><research study><sample collection><screening><screenings><specimen collection><treatment center><trial design><trial enrollment><tumor><under representation of groups><under represented groups><under represented people><under represented populations><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved group><underserved individual><underserved people>